{"id":298,"date":"2026-10-29T15:01:35","date_gmt":"2026-10-29T19:01:35","guid":{"rendered":"https:\/\/blogs.duanemorris.com\/antitrustlaw\/?p=298"},"modified":"2026-10-29T15:01:37","modified_gmt":"2026-10-29T19:01:37","slug":"pennsylvania-ag-tests-states-antitrust-enforcement-by-suing-insulin-manufacturers-and-pbms","status":"publish","type":"post","link":"https:\/\/blogs.duanemorris.com\/antitrustlaw\/2026\/10\/29\/pennsylvania-ag-tests-states-antitrust-enforcement-by-suing-insulin-manufacturers-and-pbms\/","title":{"rendered":"Pennsylvania AG Tests State\u2019s Antitrust Enforcement by Suing Insulin Manufacturers and PBMs \u00a0"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">By <a href=\"https:\/\/www.duanemorris.com\/attorneys\/jonathanlswichar.html\">Jonathan L. Swichar<\/a>, <a href=\"https:\/\/www.duanemorris.com\/attorneys\/bradleyawasser.html\">Bradley A. Wasser<\/a>, \u00a0<a href=\"https:\/\/www.duanemorris.com\/attorneys\/seanpmcconnell.html\">Sean P. McConnell<\/a>, <a href=\"https:\/\/www.duanemorris.com\/attorneys\/christopherhcasey.html\">Christopher H. Casey<\/a> and <a href=\"https:\/\/www.duanemorris.com\/attorneys\/patrickjgavin.html\">Patrick Gavin<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">On October 9, 2026, the Pennsylvania Attorney General\u2019s Office sued the country\u2019s three largest pharmacy benefit managers and three largest insulin manufacturers, alleging that they participated in an alleged insulin-pricing scheme. According to the complaint, the manufacturers raised list prices for their diabetes drugs and secretly paid rebates and fees to the PBMs in exchange for preferred formulary placement of those drugs, while the PBMs excluded lower-priced alternatives and profited from the inflated prices. The Pennsylvania attorney general\u2019s lawsuit is significant because Pennsylvania\u2014unlike all other states\u2014has no general antitrust statute. The complaint alleges that the defendants\u2019 conduct violates Pennsylvania\u2019s consumer protection statute, the Unfair Trade Practices and Consumer Protection Law.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/emarketing.duanemorris.com\/e\/rjkwbeytvyi3btq\/6d8d73d2-b26d-4cf7-a28b-496b8658077b\" target=\"_blank\" rel=\"noopener\">Read the full story on the Duane Morris LLP website<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>By Jonathan L. Swichar, Bradley A. Wasser, \u00a0Sean P. McConnell, Christopher H. Casey and Patrick Gavin On October 9, 2026, the Pennsylvania Attorney General\u2019s Office sued the country\u2019s three largest pharmacy benefit managers and three largest insulin manufacturers, alleging that they participated in an alleged insulin-pricing scheme. According to the complaint, the manufacturers raised list &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/blogs.duanemorris.com\/antitrustlaw\/2026\/10\/29\/pennsylvania-ag-tests-states-antitrust-enforcement-by-suing-insulin-manufacturers-and-pbms\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Pennsylvania AG Tests State\u2019s Antitrust Enforcement by Suing Insulin Manufacturers and PBMs \u00a0&#8220;<\/span><\/a><\/p>\n","protected":false},"author":6,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[],"ppma_author":[5],"class_list":["post-298","post","type-post","status-publish","format-standard","hentry","category-general"],"authors":[{"term_id":5,"user_id":6,"is_guest":0,"slug":"duanemorris3","display_name":"Duane Morris","avatar_url":"https:\/\/secure.gravatar.com\/avatar\/7e1f720079bb9c5f7f3d02f11a102b31d50b9071b40283de6cf5ac7a5e6f35b7?s=96&d=blank&r=g","author_category":"1","last_name":"Davies","first_name":"Thomas","job_title":"","user_url":"https:\/\/www.duanemorris.com","description":"<a href=\"http:\/\/www.duanemorris.com\">Visit the Duane Morris website.<\/a>"}],"_links":{"self":[{"href":"https:\/\/blogs.duanemorris.com\/antitrustlaw\/wp-json\/wp\/v2\/posts\/298","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.duanemorris.com\/antitrustlaw\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.duanemorris.com\/antitrustlaw\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/antitrustlaw\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/antitrustlaw\/wp-json\/wp\/v2\/comments?post=298"}],"version-history":[{"count":2,"href":"https:\/\/blogs.duanemorris.com\/antitrustlaw\/wp-json\/wp\/v2\/posts\/298\/revisions"}],"predecessor-version":[{"id":300,"href":"https:\/\/blogs.duanemorris.com\/antitrustlaw\/wp-json\/wp\/v2\/posts\/298\/revisions\/300"}],"wp:attachment":[{"href":"https:\/\/blogs.duanemorris.com\/antitrustlaw\/wp-json\/wp\/v2\/media?parent=298"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/antitrustlaw\/wp-json\/wp\/v2\/categories?post=298"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/antitrustlaw\/wp-json\/wp\/v2\/tags?post=298"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/antitrustlaw\/wp-json\/wp\/v2\/ppma_author?post=298"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}